2016, Number 4
<< Back Next >>
Rev Hematol Mex 2016; 17 (4)
Primary adrenal lymphoma: a report of two cases and review of the disease in Latin America
Jaramillo-Calle DA, Giraldo MB, Quintero-Múnera CD, Mejía-Buriticá L, Pinzón-Tovar A, Cubillos J, Luna R, Rendón-Henao J, Román-González A
Language: Spanish
References: 15
Page: 293-300
PDF size: 565.87 Kb.
ABSTRACT
Primary adrenal lymphoma is a rare disease with around 200 case
reports, of which only 4 come from Latin America. In this article, two
new cases in the region are reported which were initially considered
to be urolithiasis and pheochromocytoma. Our aim is to show the
importance of considering this entity in the differential of atypical
cases of abdominal pain and diagnostic images of masses in the adrenal
area. Besides, review all the Latin-American cases and describe
the most common clinical presentations and outcomes. The first case
is a 53 years-old man with acute abdominal pain and B-symptoms
in who initially urolithiasis was suspected, but whose CT urography
demonstrated a left adrenal mass, which was subsequently identified
by histology as a diffuse large B-cell lymphoma, against which he was
treated with R-CHOP chemotherapy up to achieving complete remission.
The second case is a 21 years-old man with a personal history of
schizophrenia who presented acute hypogastric pain associated with
facial flushing, profuse sweating, palpitations, a mass in the adrenal
area, and a slightly increasing of catecholamines, reasons why he was
initially diagnosed with pheochromocytoma. However, the histopathologic
study identified the mass as a diffuse large B-cell lymphoma
without medullary neoplasia, so he was treated with R-CHOP until
his death. After analyzing the 6 Latin-American cases together it was
found that they frequently presented severe neurological symptoms
due to dissemination of the lymphoma to central nervous system and
they were diagnosed in advanced stages.
REFERENCES
Sierra JA, Núñez HL, Bonilla LJ, Puentes CA, García E. Informe de caso. Linfoma primario bilateral de adrenales: reporte de caso y revisión de criterios inmunohistoquímicos. Patol Rev Latinoam 2011;49:18-25. http://www. medigraphic.com/pdfs/patrevlat/rlp-2011/rlps111e.pdf
Nacif MS, Jauregui GF, Andrade F de Mello R, Heizer M, et al. Linfoma adrenal primário bilateral com envolvimento do sistema nervoso central: relato de caso. Radiol Bras 2005;38:235-238. doi:10.1590/S0100- 39842005000300014
Meneses L, Meneses A, Meneses A, Junkes A, et al. Linfoma adrenal primário apresentando-se como incidentaloma adrenal: relato de caso e revisão da literatura. Arq Catarin Med 2012;41:74-78. http://www.acm.org.br/revista/pdf/ artigos/932.pdf
Solares-Sánchez ME, Camarena-Reynoso H, Martínez- Cervera PF, Ríos MA. Linfoma adrenal bilateral. Rev Mex Urol 2011;71:352-355. http://www.medigraphic.com/ pdfs/uro/ur-2011/ur116h.pdf
Singh D, Kumar L, Sharma A, Vijayaraghavan M, et al. Adrenal involvement in non-Hodgkin’s lymphoma: four cases and review of literature. Leuk Lymphoma 2004;45:789-94. doi:10.1080/10428190310001615756
Rashidi A, Fisher SI. Primary adrenal lymphoma: a systematic review. Ann Hematol 2013;92:1583-1593. doi:10.1007/ s00277-013-1812-3
Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103:275-282. doi:10.1182/ blood-2003-05-1545
Meyer PN, Fu K, Greiner TC, Smith LM, et al. Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol 2011;29:200-207. doi:10.1200/ JCO.2010.30.0368
Batlle-López A, González S, Mazorra F, Malatxeverria S, et al. Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: CG/non-CG by immunohistochemistry is still a robust and feasible marker. Oncotarget 2016;7:18036-18049. doi:10.18632/ oncotarget.7495
Nowakowski GS, Czuczman MS. ABC, GCB, and doublehit diffuse large B-cell lymphoma: does subtype make a difference in therapy selection? Am Soc Clin Oncol Educ Book 2015;449-457. doi:10.14694/EdBook_AM.2015.35. e449
Burneo M, Pérez MD, García LB, Osorio S y col. Linfoma no- Hodgkin suprarrenal primario. Rev Cuba Cir 2014;53:318- 323. http://scielo.sld.cu/scielo.php?script=sci_arttext&pi d=S0034-74932014000300012
Kim YR, Kim JS, Min YH, HyunYoon D, et al. Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL). J Hematol Oncol 2012;5:49. doi:10.1186/1756-8722-5-4
Caliskan S, Yencilek E. Large B-cell lymphoma mimicking adrenal pheochromocytoma. Indian J Med Res 2013;138:276. http://icmr.nic.in/ijmr/2013/august/clinical image2.pdf
Wang Q, Cao X, Jiang J, Wang T, Jin MS. Bilateral primary adrenal lymphoma accompanying hypertension. Urology 2012;79:27-28. doi:10.1016/j.urology.2011.06.032
Babinska A, Peksa R, Sworczak K. Primary malignant lymphoma combined with clinically “silent” pheochromocytoma in the same adrenal gland. World J Surg Oncol 2015;13:289. doi:10.1186/s12957-015-0711